Skip to content
10-Q

Quarterly Report

Aeon Global Health Corp.

0001104659-19-036025

← back to feed
Filed
Jun 18, 2019 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Jun 13, 2019 9.92M sh
Shares Diluted Q3 2019 · Mar 31, 2019 8.16M sh
Shares Diluted Q3 2019 · Mar 31, 2019 7.63M sh
Shares Diluted Q3 2019 · Mar 31, 2018 7.25M sh
Shares Diluted Q3 2019 · Mar 31, 2018 7.25M sh
Operating Cash Flow Q3 2019 · Mar 31, 2019 −$202.35K
Operating Cash Flow restated Q3 2019 · Mar 31, 2018 −$1.27M
Cash And Equivalents Q3 2019 · Mar 31, 2019 $521K
Cash And Equivalents Q3 2019 · Jun 30, 2018 $723.35K
Stockholders Equity Q3 2019 · Mar 31, 2019 $1.19M
Stockholders Equity Q3 2019 · Dec 31, 2018 $1.54M
Stockholders Equity Q3 2019 · Jun 30, 2018 $470.22K
Stockholders Equity restated Q3 2019 · Mar 31, 2018 $2.62M
Stockholders Equity Q3 2019 · Dec 31, 2017 $3.97M
Stockholders Equity restated Q3 2019 · Jun 30, 2017 $8.05M
Current Liabilities Q3 2019 · Mar 31, 2019 $7.78M
Current Liabilities Q3 2019 · Jun 30, 2018 $10.37M
Total Liabilities Q3 2019 · Mar 31, 2019 $9.4M
Total Liabilities Q3 2019 · Jun 30, 2018 $10.51M
Current Assets Q3 2019 · Mar 31, 2019 $3.72M
Current Assets Q3 2019 · Jun 30, 2018 $3.74M
Total Assets Q3 2019 · Mar 31, 2019 $10.6M
Total Assets Q3 2019 · Jun 30, 2018 $10.98M
Eps Diluted Q3 2019 · Mar 31, 2019 −$0.04
Eps Diluted Q3 2019 · Mar 31, 2019 −$0.14
Eps Diluted Q3 2019 · Mar 31, 2018 −$0.25
Eps Diluted restated Q3 2019 · Mar 31, 2018 −$0.84
Eps Basic Q3 2019 · Mar 31, 2019 −$0.04
Eps Basic Q3 2019 · Mar 31, 2019 −$0.14
Eps Basic Q3 2019 · Mar 31, 2018 −$0.25
Eps Basic restated Q3 2019 · Mar 31, 2018 −$0.84
Sga Expense Q3 2019 · Mar 31, 2019 $1.7M
Sga Expense Q3 2019 · Mar 31, 2019 $6.4M
Sga Expense restated Q3 2019 · Mar 31, 2018 $2.62M
Sga Expense restated Q3 2019 · Mar 31, 2018 $8.78M
Net Income Q3 2019 · Mar 31, 2019 −$271K
Net Income Q3 2019 · Mar 31, 2019 −$836.89K
Net Income restated Q3 2019 · Mar 31, 2018 −$1.71M
Net Income restated Q3 2019 · Mar 31, 2018 −$5.82M
Operating Income Q3 2019 · Mar 31, 2019 −$381.69K
Operating Income Q3 2019 · Mar 31, 2019 −$1.06M
Operating Income Q3 2019 · Mar 31, 2018 −$329.12K
Operating Income Q3 2019 · Mar 31, 2018 −$85.48K
Cost Of Revenue Q3 2019 · Mar 31, 2019 $1.14M
Cost Of Revenue Q3 2019 · Mar 31, 2019 $3.8M
Cost Of Revenue Q3 2019 · Mar 31, 2018 $958.11K
Cost Of Revenue Q3 2019 · Mar 31, 2018 $2.98M